The European Commission decided on Thursday to fine Teva Pharmaceutical Industries Ltd. €462.6 million for the abuse of its dominant market position. The Commission found the Israeli company artificially extended the patent protection of its multiple sclerosis medicine Copaxone in multiple...
The European Commission said on Thursday that it has opened a formal antitrust investigation into Teva Pharmaceutical Industries Ltd. The Commission will look into whether the pharmaceutical company "illegally delayed the market entry and uptake of medicines" that compete with its multiple...
European Commission decided to fine Teva Pharmaceutical Industries Ltd. and Cephalon Inc. for agreeing to delay the market entry of Teva's cheaper generic version of Cephalon's sleeping disorder medicine, modafinil, Executive Vice-President Margrethe Vestager announced on Thursday. She added...
United States President Donald Trump talking in front of the White House on Monday, praised various pharmaceutical companies for their work in producing Hydroxychloroquine, an anti-malaria drug that has been tested as a treatment for COVID-19 and make it available to the US hospitals and...
Teva Pharmaceutical Industries Ltd. announced on Monday it entered into an agreement for a global settlement framework through which it will attempt to seek resolution of potential and pending opioid claims, confirming earlier rumors.
Under the terms of the agreement, the company...
Four pharmaceutical companies, McKesson Corp., Teva Pharmaceutical Industries Ltd., AmerisourceBergen Corp. and Cardinal Health Inc. reached a settlement on Monday in order to avoid a trial.
According to persons familiar with the situation, the details of the settlement should be released later...
The negotiations with drug distributors hit a wall on Friday at the Northern District of Ohio, lawyer Paul Hanly said on behalf of thousands of local authorities in the United States which sued them and pharmaceutical producers for the opioid crisis. US states were apparently more inclined to settle...
The advisory group of the European Medicines Agency (EMA) and the Committee for Medicinal Products for Human Use (CHMP), recommended on Friday the approval of a new drug against migraine "Ajovy," produced by Teva Pharmaceutical Industries Ltd.
The final decision by the European...
Shares of Israeli pharmaceutical company Teva Pharmaceutical Industries Ltd. surged over 6% following news that the United States Food and Drug Administration approved its generic version of the EpiPen and EpiPen Jr on Thursday. Teva soared 6.28% at 7:23 pm CET to $23.89 per share.
"Today’s...
Warren Buffett's holding Berkshire Hathaway Inc. revealed on Wednesday that it purchased $358 million worth of stake in Israel-based Teva Pharmaceutical Industries Ltd. The investment equals to 18.9 million American depositary receipts (ADRs) or 1.9% of the company.
Shortly after the...
This website uses cookies to ensure you get the best experience. Our Terms of Use and Data Protection Policy explain the data we collect, why we collect them, and how we may share them.
